Sector: MedicalImmunoGen, Inc. (NASDAQ: IMGN)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 278 |
Technical : | 55 |
Performance : | 268 |
Overall: | 249 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 277 |
Technical : | 86 |
Performance : | 273 |
Overall: | 260 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 277 |
Technical : | 190 |
Performance : | 273 |
Overall: | 295 |
Number of Stocks: | 305 |
Headlines
- ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results
Oct 29, 2009 04:01 PM | IMGN
- ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 20th Annual Healthcare Conference
Oct 27, 2009 06:30 AM | IMGN
- Get Instant Biotech Diversification
Oct 22, 2009 01:09 PM | AMGN, BBI, GENZ, IMGN
- ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2010 Financial Results
Oct 22, 2009 06:30 AM | IMGN
- ImmunoGen Announces Amgen has Licensed Rights to Use the Company's TAP Technology for a Solid Tumor Target
Sep 16, 2009 04:01 PM | AMGN, IMGN
- ImmunoGen, Inc. Announces Webcast of Presentations at Two Investor Conferences
Sep 02, 2009 10:00 AM | IMGN
- The Clock Is Ticking On Micromet (MITI)
Aug 24, 2009 08:10 PM | AZN, BMY, EXEL, IMGN, MITI, RBC
- ImmunoGen, Inc. Appoints Peter Williams as Vice President, Business Development
Aug 17, 2009 06:30 AM | ALNY, IMGN
- Curagen (NasdaqGM: CRGN)– Positive Results At ASCO 2009
Jul 07, 2009 09:30 AM | CRGN, IMGN, SGEN
- Immunogen (Nasdaq: IMGN): Antibody Play
Jul 01, 2009 10:11 AM | IMGN
- ImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Aug 06, 2009 04:10 PM | IMGN
- ImmunoGen, Inc. Announces Webcast of Presentation at the 29th Annual Canaccord Adams Global Growth Conference
Aug 05, 2009 10:19 AM | IMGN
- ImmunoGen Announces Encouraging New Clinical Data with the Company’s IMGN901 Compound in the Treatment of Small-Cell Lung Cancer
Jul 31, 2009 10:31 PM | IMGN
- ImmunoGen, Inc. Announces Conference Call to Discuss its Fourth Quarter and Fiscal Year 2009 Financial Results
Jul 30, 2009 06:31 AM | IMGN
- ImmunoGen, Inc. Announces Completion of Public Offering of Common Stock
Jun 23, 2009 04:05 PM | IMGN
- ImmunoGen, Inc. Announces Exercise of Over-Allotment Option
Jun 22, 2009 09:53 AM | AMGN, IMGN
- ImmunoGen, Inc. Prices Public Offering of Common Stock
Jun 18, 2009 09:21 AM | IMGN
- ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock
Jun 17, 2009 04:06 PM | IMGN
- ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound
Jun 11, 2009 04:04 PM | IMGN
- ImmunoGen, Inc. Announces Encouraging Trastuzumab-DM1 Phase II Clinical Findings Presented at ASCO
May 30, 2009 08:03 AM | IMGN
- Form 4 IMMUNOGEN INC For: Nov 02 Filed by: CARTER DAVID WARREN (10K)
Nov 04, 2009 08:40 AM
- Form 4 VILLAFRANCA JOSEPH J For: Aug 12 (10K)
Aug 13, 2009 03:47 PM
- Form 4 KORSANT PHILIP B For: Jul 31 (10K)
Jul 31, 2009 07:26 PM
- Form 4 O'Leary James J For: Jul 24 (10K)
Jul 27, 2009 06:12 PM
- Form 4 JUNIUS DANIEL M For: Jul 24 (10K)
Jul 27, 2009 06:12 PM
- Form 4 PERRY GREGORY D For: Jul 24 (10K)
Jul 27, 2009 06:11 PM
- Form 4 IMMUNOGEN INC For: Jul 24 Filed by: LAMBERT JOHN (10K)
Jul 27, 2009 06:11 PM
- Form 4/A VILLAFRANCA JOSEPH J For: May 12 (10K)
Jul 06, 2009 11:55 AM
- Form 4/A VILLAFRANCA JOSEPH J For: Feb 12 (10K)
Jul 06, 2009 11:55 AM
- Form 4 IMMUNOGEN INC For: Jan 09 Filed by: PERRY GREGORY D (10K)
Jan 12, 2009 11:04 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
IMGN
|
Compare to S&P
|
| YTD |
55.94 %
|
35.94 %
|
| 4 Weeks |
-10.44 %
|
-11.39 %
|
| 12 Weeks |
-10.68 %
|
-12.90 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -4.76 %
|
|
EPS Growth in Last Year: -15.79 %
|
|
Sales Growth in Last Quarter: -27.96 %
|
|
Sales Growth in Last Quarter: -49.41 %
|
|
